Detalles de la búsqueda
1.
A randomized, double-blind, phase III study assessing clinical similarity of SB17 (proposed ustekinumab biosimilar) to reference ustekinumab in subjects with moderate-to-severe plaque psoriasis.
J Am Acad Dermatol
; 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685404
2.
17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Am J Perinatol
; 37(2): 127-136, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31652479
3.
Ex vivo comparative immunogenicity assessment (EVCIA) to determine relative immunogenicity in chronic plaque psoriasis in participants receiving Humira® or undergoing repeated switches between Humira® and AVT02.
Immunother Adv
; 4(1): ltad029, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38268817
4.
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
BioDrugs
; 38(1): 121-131, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991693
5.
Randomized, double-blind, multicenter study to evaluate efficacy, safety, tolerability, and immunogenicity between AVT04 and the reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis.
Expert Opin Biol Ther
; 23(8): 759-771, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37435850
6.
Assessing the Interchangeability of AVT02 and Humira® in Participants with ModeratetoSevere Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study.
BioDrugs
; 37(4): 551-567, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37204631
7.
Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study.
BioDrugs
; 35(6): 735-748, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657274
Resultados
1 -
7
de 7
1
Próxima >
>>